ESTA 📈 Establishment Labs Holdings - Overview
Exchange: NASDAQ • Country: Costa Rica • Currency: USD • Type: Common Stock • ISIN: VGG312491084
ESTA: Breast Implants, Tissue Expanders
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica. Web URL: https://www.establishmentlabs.com
Additional Sources for ESTA Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ESTA Stock Overview
| Market Cap in USD | 1,318m |
| Sector | Healthcare |
| Industry | Medical Devices |
| GiC Sub-Industry | Health Care Supplies |
| IPO / Inception | 2018-07-19 |
ESTA Stock Ratings
| Growth 5y | 19.8% |
| Fundamental | -52.9% |
| Dividend | - |
| Rel. Strength Industry | 1324 |
| Analysts | 4.57/5 |
| Fair Price Momentum | 36.47 USD |
| Fair Price DCF | - |
ESTA Dividends
No Dividends PaidESTA Growth Ratios
| Growth Correlation 3m | 17.2% |
| Growth Correlation 12m | 6.3% |
| Growth Correlation 5y | 14.6% |
| CAGR 5y | 7.95% |
| CAGR/Mean DD 5y | 0.25 |
| Sharpe Ratio 12m | 0.99 |
| Alpha | 27.07 |
| Beta | 1.40 |
| Volatility | 58.29% |
| Current Volume | 374.4k |
| Average Volume 20d | 387.5k |
What is the price of ESTA stocks?
As of December 21, 2024, the stock is trading at USD 40.01 with a total of 374,375 shares traded.
Over the past week, the price has changed by -13.02%, over one month by -4.31%, over three months by -5.75% and over the past year by +73.28%.
As of December 21, 2024, the stock is trading at USD 40.01 with a total of 374,375 shares traded.
Over the past week, the price has changed by -13.02%, over one month by -4.31%, over three months by -5.75% and over the past year by +73.28%.
Is Establishment Labs Holdings a good stock to buy?
No, based on ValueRay Fundamental Analyses, Establishment Labs Holdings (NASDAQ:ESTA) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -52.90 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ESTA as of December 2024 is 36.47. This means that ESTA is currently overvalued and has a potential downside of -8.85%.
No, based on ValueRay Fundamental Analyses, Establishment Labs Holdings (NASDAQ:ESTA) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -52.90 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ESTA as of December 2024 is 36.47. This means that ESTA is currently overvalued and has a potential downside of -8.85%.
Is ESTA a buy, sell or hold?
Establishment Labs Holdings has received a consensus analysts rating of 4.57. Therefor, it is recommend to buy ESTA.
Establishment Labs Holdings has received a consensus analysts rating of 4.57. Therefor, it is recommend to buy ESTA.
- Strong Buy: 5
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for ESTA stock price target?
According to ValueRays Forecast Model, ESTA Establishment Labs Holdings will be worth about 40.8 in December 2025. The stock is currently trading at 40.01. This means that the stock has a potential upside of +1.85%.
According to ValueRays Forecast Model, ESTA Establishment Labs Holdings will be worth about 40.8 in December 2025. The stock is currently trading at 40.01. This means that the stock has a potential upside of +1.85%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 60.3 | 50.7% |
| Analysts Target Price | 87.9 | 119.6% |
| ValueRay Target Price | 40.8 | 1.8% |